Staphylococcus aureus

Staphylococcus aureus
source
Name	Staphylococcus aureus
Domain	Bacteria
Phylum	Bacillota
Class	Bacilli
Order	Bacillales
Family	Staphylococcaceae
Genus	Staphylococcus
Species	S. aureus
Binomial	Staphylococcus aureus
Binomial authority	Rosenbach 1884

Staphylococcus aureus is a Gram-positive, round-shaped bacterium that is a common member of the human microbiota, frequently found in the respiratory tract and on the skin. It is often harmless but can become a formidable pathogen, responsible for a wide spectrum of illnesses, from minor skin infections to life-threatening conditions like pneumonia and sepsis. The organism is notable for its virulence factors, such as the production of coagulase and enterotoxin, and its ability to develop resistance to antibiotics, most famously to methicillin in strains known as MRSA.

Characteristics

It is a facultative anaerobe that grows in clusters resembling grapes, a morphology visible under microscope and first described by Sir Alexander Ogston. The bacterium is catalase-positive and coagulase-positive, key tests used in clinical microbiology laboratories for identification, differentiating it from other species like Staphylococcus epidermidis. Its cell wall contains peptidoglycan and teichoic acid, and many strains possess a polysaccharide capsule. A defining feature is its production of a golden-yellow pigment on culture media, a trait observed by Friedrich Julius Rosenbach that gave the species its name. It is remarkably hardy, capable of surviving for extended periods on dry surfaces and tolerating high sodium chloride concentrations.

Pathogenesis

Its disease-causing potential stems from a vast arsenal of virulence factors. Surface proteins like protein A and clumping factor promote evasion of the immune system and adherence to host tissues. It secretes a plethora of toxins, including cytolytic peptides like alpha-toxin and Panton-Valentine leukocidin, which damage cell membranes. Superantigens such as toxic shock syndrome toxin-1 can cause massive, dysregulated T cell activation. The bacterium also produces enzymes like hyaluronidase and lipase that facilitate tissue invasion and spread. A critical aspect of its pathogenicity is its ability to form biofilm on medical devices like catheters and prosthetic joints, protecting it from both immune responses and antimicrobial agents.

Clinical significance

It causes a diverse array of infections, commonly presenting as folliculitis, furuncles, carbuncles, and impetigo. More serious skin and soft tissue infections include cellulitis and necrotizing fasciitis. It is a leading cause of bacteremia, infective endocarditis, osteomyelitis, and septic arthritis. In healthcare settings, it is associated with surgical site infections and ventilator-associated pneumonia. Toxin-mediated diseases include staphylococcal scalded skin syndrome, food poisoning from pre-formed enterotoxin, and toxic shock syndrome, famously associated with the Rely tampon crisis in the 1980s.

Treatment and prevention

Treatment depends on the infection's severity and the strain's susceptibility. For susceptible strains, penicillinase-stable beta-lactam antibiotics like nafcillin or cephalosporins are first-line. The emergence of MRSA necessitates alternatives such as vancomycin, daptomycin, or linezolid. Prevention strategies in hospitals, guided by organizations like the Centers for Disease Control and Prevention, emphasize hand hygiene, contact precautions for carriers, and decolonization protocols using mupirocin or chlorhexidine. In the community, emphasis is on wound care and avoiding sharing personal items. Research into vaccine candidates, such as those targeting the capsular polysaccharide, has been pursued by companies like Pfizer and Novartis but has not yet yielded a licensed product.

Epidemiology

It is a ubiquitous organism, with approximately 30% of the human population being asymptomatic carriers, often in the anterior nares. The burden of disease is substantial globally, with both community-associated and healthcare-associated strains causing significant morbidity and mortality. The spread of MRSA, first reported in the United Kingdom in 1961, became a major public health crisis, with notable outbreaks in institutions like the National Football League. Surveillance networks, such as the Active Bacterial Core surveillance system in the United States and the European Antimicrobial Resistance Surveillance Network, track its prevalence and resistance patterns.

Research

Ongoing research is extensive, focusing on understanding resistance mechanisms, such as the acquisition of the mecA gene found on the staphylococcal cassette chromosome mec. Studies at institutions like the National Institute of Allergy and Infectious Diseases investigate novel therapeutic approaches, including phage therapy, monoclonal antibody treatments, and new antimicrobial peptides. The molecular basis of quorum sensing via the accessory gene regulator system and biofilm formation is a key area of study for developing anti-virulence strategies. Genomic epidemiology, using techniques like whole-genome sequencing, is crucial for tracking outbreak strains, as demonstrated during investigations of USA300, a prevalent community-associated MRSA clone.

Category:Bacteria Category:Pathogenic bacteria